Physician profile
Julie Becker
NPI 1215005194
$2,722.60
in general payments reported to CMS, 2019-2025
28 companies · $348 in 2025
The $348 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $551 · 2022: $588 · 2023: $702 · 2024: $534 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,489 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,488.68 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $410.41 | 2021-2024 | |
| Novo Nordisk INC | $372.75 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $313.22 | 2021-2025 | |
| Exact Sciences Corporation | $192.73 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $177.91 | 2021-2024 | |
| Astellas Pharma US INC | $173.69 | 2023-2025 | Veozah |
| Abbott Laboratories | $164.74 | 2022-2025 | Freestyle Libre 2, Freestyle Libre 3, Proclaim |
| Glaxosmithkline, LLC. | $144.78 | 2021-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.28 | 2021-2024 | Jardiance |
| Lilly USA, LLC | $104.99 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $83.55 | 2021-2024 | Airsupra, Farxiga |
| Amgen INC. | $68.77 | 2022-2025 | Repatha, Otezla, Repatha |
| Seqirus USA INC | $62.89 | 2021-2025 | Fluad, Flucelvax |
| Teva Pharmaceuticals USA, INC. | $58.28 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $35.26 | 2025 | Capvaxive, Gardasil 9, Vaxneuvance |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $27.98 | 2022 | |
| Sanofi Pasteur INC. | $26.61 | 2024 | |
| Hologic Sales and Service, LLC | $25.30 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $24.81 | 2023 | Uptravi, Opsumit |
| Tolmar, INC. | $18.42 | 2025 | Jatenzo |
| Philips North America LLC | $17.26 | 2024 | (Ck7) Extended Holter |
| Aimmune Therapeutics, INC. | $16.93 | 2025 | Zenpep |
| Modernatx, INC. | $15.78 | 2024 | Moderna Covid-19 Vaccine |
| Idorsia Pharmaceuticals US INC | $15.00 | 2023 | Quviviq |
| Janssen Pharmaceuticals, INC | $14.43 | 2021 | |
| Esperion Therapeutics, INC. | $14.33 | 2021 | |
| Genentech USA, INC. | $14.26 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.